Where’s the data? In a pandemic, now is no time to sit on Covid-19 trial results
GILEAD SCIENCES VIA AP
Two weeks after the dislosure of data on Gilead's remdesivir, the public still hasn't seen full results, leaving others without critical insights.
No hay comentarios:
Publicar un comentario